Caroline Helwick[email protected]MRIBreast MRI pinpoints residual disease after chemotherapyBreast MRI accurately reflects the pathologic extent of residual disease following neoadjuvant chemotherapy, and tumor size and contrast kinetics measured by MRI may be useful early predictors of treatment response, according to a study presented at the San Antonio Breast Cancer Symposium.December 18, 2008Page 1 of 1Top StoriesWomens ImagingRadiologist performance, patient factors tied to interval cancer riskBreast density, family history of breast cancer, and inadequate radiologist performance influence interval breast cancer risk.Practice ManagementMICI Q4: Radiology admins' confidence varies regarding medical imagingRSNA 2025Image-only AI model improves breast cancer risk assessmentRSNA 2025Brain MRI reveals pro fighters' risk of waste clearing system damageSponsor ContentClinically Meaningful AI Detection of Interval Cancers